Literature DB >> 12297914

Multifactorial risk profile for bone fractures in primary hyperparathyroidism.

Erik Nordenström1, Johan Westerdahl, Birger Lindergård, Pia Lindblom, Anders Bergenfelz.   

Abstract

Primary hyperparathyroidism (pHPT) is associated with an increased fracture risk, and decreased bone density thus has been considered an indication for surgery. However, many pHPT patients have a multifactorial risk profile for osteoporosis and bone fractures. The aim of the present study was to evaluate variables associated with fracture risk within the group of pHPT patients. A series of 203 consecutive patients operated for pHPT were investigated with bone mineral content and biochemical and clinical risk factors for bone fracture. Seventeen patients (8%) had a history of at least one bone fracture up to 5 years before pHPT surgery. Twenty-six patients (13%) had a history of at least one fracture during the 10-year period prior to surgery. In the univariate analyses corticosteroid treatment, serum levels of alkaline phosphatase, 25-hydroxyvitamin D3, type I collagen telopeptide, and bone mineral content were found to be associated with a history of bone fractures up to 10 years before surgery. Additionally, age and menopausal status were of importance for fractures during the 10-year-period, whereas a history of cardiovascular disease was important for fractures during the 5-year-period prior to surgery. Multivariate analyses showed that serum level of PTH was independently associated with bone fractures during the 5-year period prior to pHPT surgery and further that serum level of 25-hydroxyvitamin D3 was associated with fractures up to 10 years before surgery. In conclusion, serum levels of 25-hydroxyvitamin D3 and PTH were independently associated with a history of bone fractures in pHPT. These variables should be considered when evaluating patients for parathyroid surgery.

Entities:  

Mesh:

Year:  2002        PMID: 12297914     DOI: 10.1007/s00268-002-6433-2

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  32 in total

1.  Vitamin D deficiency and primary hyperparathyroidism presenting with repeated fractures.

Authors:  W Wassif; I Kaddam; M Prentice; S J Iqbal; A Richardson
Journal:  J Bone Joint Surg Br       Date:  1991-03

2.  Bone mineral content in patients with primary hyperparathyroidism: a comparison of conservative management with surgical treatment.

Authors:  P A Mole; M H Walkinshaw; A Gunn; C R Paterson
Journal:  Br J Surg       Date:  1992-03       Impact factor: 6.939

3.  Characterization and evaluation of asymptomatic primary hyperparathyroidism.

Authors:  J P Bilezikian; S J Silverberg; E Shane; M Parisien; D W Dempster
Journal:  J Bone Miner Res       Date:  1991-10       Impact factor: 6.741

4.  Asymptomatic primary hyperparathyroidism discovered by multichannel biochemical screening: clinical course and considerations bearing on the need for surgical intervention.

Authors:  A M Parfitt; D S Rao; M Kleerekoper
Journal:  J Bone Miner Res       Date:  1991-10       Impact factor: 6.741

5.  Serum vitamin D metabolite concentrations in primary hyperparathyroidism.

Authors:  M T Nikkilä; J J Saaristo
Journal:  Ann Med       Date:  1989-08       Impact factor: 4.709

6.  Sequential changes in bone density before and after parathyroidectomy in primary hyperparathyroidism.

Authors:  D C Leppla; W Snyder; C Y Pak
Journal:  Invest Radiol       Date:  1982 Nov-Dec       Impact factor: 6.016

7.  Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism.

Authors:  P Vestergaard; C L Mollerup; V G Frøkjaer; P Christiansen; M Blichert-Toft; L Mosekilde
Journal:  BMJ       Date:  2000-09-09

8.  Primary hyperparathyroidism. A review of the long-term surgical and nonsurgical morbidities as a basis for a rational approach to treatment.

Authors:  F W Lafferty; C A Hubay
Journal:  Arch Intern Med       Date:  1989-04

9.  Plasma clearance of a new contrast agent, iohexol: a method for the assessment of glomerular filtration rate.

Authors:  E Krutzén; S E Bäck; I Nilsson-Ehle; P Nilsson-Ehle
Journal:  J Lab Clin Med       Date:  1984-12

10.  Asymptomatic primary hyperparathyroidism.

Authors:  B H Mitlak; M Daly; J T Potts; D Schoenfeld; R M Neer
Journal:  J Bone Miner Res       Date:  1991-10       Impact factor: 6.741

View more
  13 in total

1.  A very high incidence of low 25 hydroxy-vitamin D serum concentration in a French population of patients with primary hyperparathyroidism.

Authors:  P Boudou; F Ibrahim; C Cormier; E Sarfati; J C Souberbielle
Journal:  J Endocrinol Invest       Date:  2006-06       Impact factor: 4.256

2.  Vitamin D in Primary Hyperparathyroidism: Effects on Clinical, Biochemical, and Densitometric Presentation.

Authors:  Marcella D Walker; Elaine Cong; James A Lee; Anna Kepley; Chiyuan Zhang; Donald J McMahon; Shonni J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2015-06-16       Impact factor: 5.958

3.  Bone mineral density in menopausal women with primary hyperparathyroidism before and after parathyroidectomy.

Authors:  Antonio Sitges-Serra; Meritxell Girvent; José A Pereira; Jaime Jimeno; Xavier Nogués; Francisco J Cano; Joan J Sancho
Journal:  World J Surg       Date:  2004-11       Impact factor: 3.352

4.  Vitamin D deficiency influences histomorphometric features of bone in primary hyperparathyroidism.

Authors:  Emily M Stein; David W Dempster; Julia Udesky; Hua Zhou; John P Bilezikian; Elizabeth Shane; Shonni J Silverberg
Journal:  Bone       Date:  2010-10-13       Impact factor: 4.398

5.  Biochemical effects of calcifediol supplementation in mild, asymptomatic, hyperparathyroidism with concomitant vitamin D deficiency.

Authors:  M Luisa Isidro; Belén Ruano
Journal:  Endocrine       Date:  2009-07-14       Impact factor: 3.633

6.  Recovery of bone mineral density in 126 patients after surgery for primary hyperparathyroidism.

Authors:  Erik Nordenström; Johan Westerdahl; Anders Bergenfelz
Journal:  World J Surg       Date:  2004-04-19       Impact factor: 3.352

7.  Management of hypovitaminosis D in patients with primary hyperparathyroidism.

Authors:  M S Rathi; S Gonzalez; D Wright; N R Ellis; S R Peacey
Journal:  J Endocrinol Invest       Date:  2014-02-11       Impact factor: 4.256

8.  Impact of vitamin D deficiency on the clinical and biochemical phenotype in women with sporadic primary hyperparathyroidism.

Authors:  Giuseppe Viccica; Filomena Cetani; Edda Vignali; Mario Miccoli; Claudio Marcocci
Journal:  Endocrine       Date:  2016-03-31       Impact factor: 3.633

Review 9.  Primary hyperparathyroidism.

Authors:  Marcella D Walker; Shonni J Silverberg
Journal:  Nat Rev Endocrinol       Date:  2017-09-08       Impact factor: 43.330

Review 10.  Peer-reviewed, evidence-based analysis of vitamin D and primary hyperparathyroidism.

Authors:  Storm Weaver; David B Doherty; Camilo Jimenez; Nancy D Perrier
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.